BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24633997)

  • 1. Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?
    Dantzer R; Walker AK
    J Neural Transm (Vienna); 2014 Aug; 121(8):925-32. PubMed ID: 24633997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the Kynurenine Metabolism Pathway in Inflammation-Induced Depression: Preclinical Approaches.
    Dantzer R
    Curr Top Behav Neurosci; 2017; 31():117-138. PubMed ID: 27225497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Mild Stress Alters Kynurenine Pathways Changing the Glutamate Neurotransmission in Frontal Cortex of Rats.
    Martín-Hernández D; Tendilla-Beltrán H; Madrigal JLM; García-Bueno B; Leza JC; Caso JR
    Mol Neurobiol; 2019 Jan; 56(1):490-501. PubMed ID: 29725904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
    Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
    Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of kynurenine pathway between inflammation and glutamate in the underlying etiopathology of CUMS-induced depression mouse model.
    Wu X; Chen B; Di Z; Jiang S; Xu H; Shi M; Hu R; Sun S; Song Z; Liu J; Ma R; Guo Q
    BMC Neurosci; 2022 Nov; 23(1):62. PubMed ID: 36357867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indoleamine 2,3-Dioxygenase-Dependent Neurotoxic Kynurenine Metabolism Contributes to Poststroke Depression Induced in Mice by Ischemic Stroke along with Spatial Restraint Stress.
    Koo YS; Kim H; Park JH; Kim MJ; Shin YI; Choi BT; Lee SY; Shin HK
    Oxid Med Cell Longev; 2018; 2018():2413841. PubMed ID: 30693061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality.
    Bay-Richter C; Linderholm KR; Lim CK; Samuelsson M; Träskman-Bendz L; Guillemin GJ; Erhardt S; Brundin L
    Brain Behav Immun; 2015 Jan; 43():110-7. PubMed ID: 25124710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucine competes with kynurenine for blood-to-brain transport and prevents lipopolysaccharide-induced depression-like behavior in mice.
    Walker AK; Wing EE; Banks WA; Dantzer R
    Mol Psychiatry; 2019 Oct; 24(10):1523-1532. PubMed ID: 29988087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines.
    Zádori D; Veres G; Szalárdy L; Klivényi P; Vécsei L
    J Alzheimers Dis; 2018; 62(2):523-547. PubMed ID: 29480191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease.
    Chen LM; Bao CH; Wu Y; Liang SH; Wang D; Wu LY; Huang Y; Liu HR; Wu HG
    J Neuroinflammation; 2021 Jun; 18(1):135. PubMed ID: 34127024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells).
    Saito K; Chen CY; Masana M; Crowley JS; Markey SP; Heyes MP
    Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):11-4. PubMed ID: 8471029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinolinate as a Marker for Kynurenine Metabolite Formation and the Unresolved Question of NAD
    Moffett JR; Arun P; Puthillathu N; Vengilote R; Ives JA; Badawy AA; Namboodiri AM
    Front Immunol; 2020; 11():31. PubMed ID: 32153556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
    Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
    Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
    Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders.
    Savitz J
    Curr Top Behav Neurosci; 2017; 31():249-267. PubMed ID: 27221627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia.
    Saito K; Nowak TS; Markey SP; Heyes MP
    J Neurochem; 1993 Jan; 60(1):180-92. PubMed ID: 8417138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats.
    Braidy N; Guillemin GJ; Mansour H; Chan-Ling T; Grant R
    FEBS J; 2011 Nov; 278(22):4425-34. PubMed ID: 22032336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
    Tan L; Yu JT; Tan L
    J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kynurenine pathway in depression: A systematic review and meta-analysis.
    Ogyu K; Kubo K; Noda Y; Iwata Y; Tsugawa S; Omura Y; Wada M; Tarumi R; Plitman E; Moriguchi S; Miyazaki T; Uchida H; Graff-Guerrero A; Mimura M; Nakajima S
    Neurosci Biobehav Rev; 2018 Jul; 90():16-25. PubMed ID: 29608993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Inflammation-Associated Depression: Immune Influences on Tryptophan and Phenylalanine Metabolisms.
    Strasser B; Sperner-Unterweger B; Fuchs D; Gostner JM
    Curr Top Behav Neurosci; 2017; 31():95-115. PubMed ID: 27278641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.